Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Christian L. Hvas, Mia Bendix, Anders Dige, Jens F. Dahlerup & Jørgen Agnholt. (2018) Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacology and Immunotoxicology 40:6, pages 446-460.
Read now
Read now
Anders Dige, Maria K. Magnusson, Lena Öhman, Christian Lodberg Hvas, Jens Kelsen, Mary Jo Wick & Jørgen Agnholt. (2016) Reduced numbers of mucosal DRint macrophages and increased numbers of CD103+ dendritic cells during anti-TNF-α treatment in patients with Crohn’s disease. Scandinavian Journal of Gastroenterology 51:6, pages 692-699.
Read now
Read now
Luiz C Di Stasi, Celso ARA Costa & Aline Witaicenis. (2015) Products for the treatment of inflammatory bowel disease: a patent review (2013 – 2014). Expert Opinion on Therapeutic Patents 25:6, pages 629-642.
Read now
Read now
Aristeidis H Katsanos & Konstantinos H Katsanos. (2014) Inflammatory bowel disease and demyelination: more than just a coincidence?. Expert Review of Clinical Immunology 10:3, pages 363-373.
Read now
Read now
Articles from other publishers (21)
Hsuan Ping Chang, Valentina Shakhnovich, Adam Frymoyer, Ryan Sol Funk, Mara L. Becker, K. T. Park & Dhaval K. Shah. (2021) A population physiologically‐based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab. British Journal of Clinical Pharmacology 88:1, pages 290-302.
Crossref
Crossref
Tingyue Tu, Mao Yu, Yanping Zhang, Xiafei Shi, Jinhao Xu, Junqing Hu, Jingjing Gan, Wei He, Lei Dong, Jianlin Han, Zhen Huang, Yi Pan & Junfeng Zhang. (2018) A novel fluorinated triazole derivative suppresses macrophage activation and alleviates experimental colitis via a Twist1-dependent pathway. Biochemical Pharmacology 155, pages 275-287.
Crossref
Crossref
Oscar Hernandez-Alba, Elsa Wagner-Rousset, Alain Beck & Sarah Cianférani. (2018) Native Mass Spectrometry, Ion Mobility, and Collision-Induced Unfolding for Conformational Characterization of IgG4 Monoclonal Antibodies. Analytical Chemistry 90:15, pages 8865-8872.
Crossref
Crossref
M. Jack Borrok, Antonio DiGiandomenico, Nurten Beyaz, Gabriela M. Marchetti, Arnita S. Barnes, Kristen J. Lekstrom, Sandrina S. Phipps, Michael P. McCarthy, Herren Wu, William F. Dall’Acqua, Ping Tsui & Ruchi Gupta. (2018) Enhancing IgG distribution to lung mucosal tissue improves protective effect of anti–Pseudomonas aeruginosa antibodies. JCI Insight 3:12.
Crossref
Crossref
Jesús K. Yamamoto-Furusho & Andrea Sarmiento-Aguilar. (2017) Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study. Clinical Rheumatology 37:3, pages 677-682.
Crossref
Crossref
Anders Dige, Maria K. Magnusson, Claus Uhrenholt, Tue Kruse Rasmussen, Tue Kragstrup, Lena Öhman, Jens Dahlerup & Jørgen Agnholt. (2018)
Effects of Anti-TNF
α
Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn’s Disease
. Mediators of Inflammation 2018, pages 1-7.
Crossref
Crossref
Tianshu Xu, Tianlei Ying, Lili Wang, Xiaohua Douglas Zhang, Ying Wang, Lishan Kang, Tao Huang, Liang Cheng, Liping Wang & Qi Zhao. (2017) A native-like bispecific antibody suppresses the inflammatory cytokine response by simultaneously neutralizing tumor necrosis factor-alpha and interleukin-17A. Oncotarget 8:47, pages 81860-81872.
Crossref
Crossref
Xing Yu Jin, Dong Hwan Sohn & Sung Hee Lee. (2016) Isoliquiritigenin suppresses tumor necrosis factor-α-induced inflammation via peroxisome proliferator-activated receptor-γ in intestinal epithelial cells. Archives of Pharmacal Research 39:10, pages 1465-1471.
Crossref
Crossref
Tae Kang & Hyun Kim. (2016) Farewell to Animal Testing: Innovations on Human Intestinal Microphysiological Systems. Micromachines 7:7, pages 107.
Crossref
Crossref
B Gurram, N H Salzman, M L Kaldunski, S Jia, B U K Li, M Stephens, M R Sood & M J Hessner. (2016) Plasma-induced signatures reveal an extracellular milieu possessing an immunoregulatory bias in treatment-naive paediatric inflammatory bowel disease. Clinical and Experimental Immunology 184:1, pages 36-49.
Crossref
Crossref
Vijay Rajeshwarrao Chidrawar. (2016) Exploiting the role of various types of ion-channels against chemically induced inflammatory bowel disease in male Wistar rats. Asian Pacific Journal of Tropical Disease 6:2, pages 90-99.
Crossref
Crossref
Francesco Caso, Luisa Costa, Antonio Del Puente, Matteo Nicola Dario Di Minno, Gelsy Lupoli, Raffaele Scarpa & Rosario Peluso. (2015) Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies. Therapeutic Advances in Chronic Disease 6:6, pages 328-338.
Crossref
Crossref
Laith Alrubaiy, Ibtihal Rikaby, Mohamed Sageer, Hayley Anne Hutchings & John Gordon Williams. (2015) Systematic Review of the Clinical Disease Severity Indices for Inflammatory Bowel Disease. Inflammatory Bowel Diseases, pages 1.
Crossref
Crossref
Raquel Franco Leal, Núria Planell, Radhika Kajekar, Juan J Lozano, Ingrid Ordás, Isabella Dotti, Miriam Esteller, M Carme Masamunt, Harsukh Parmar, Elena Ricart, Julián Panés & Azucena Salas. (2015) Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy. Gut 64:2, pages 233-242.
Crossref
Crossref
A. Dige, S. Støy, K. L. Thomsen, C. L. Hvas, J. Agnholt, J. F. Dahlerup, H. J. Møller & H. Grønbaek. (2014)
Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti-TNF-
α
Antibody Treatment in Active Inflammatory Bowel Disease
. Scandinavian Journal of Immunology 80:6, pages 417-423.
Crossref
Crossref
Mark D. Turner, Belinda Nedjai, Tara Hurst & Daniel J. Pennington. (2014) Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843:11, pages 2563-2582.
Crossref
Crossref
Vincenzo Bruner, Mariangela Atteno, Angelo Spanò, Raffaele Scarpa & Rosario Peluso. (2014) Biological therapies for spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease 6:3, pages 92-101.
Crossref
Crossref
K. T. Park, Wallace V. Crandall, Jacqueline Fridge, Ian H. Leibowitz, Marc Tsou, Dana M. H. Dykes, Edward J. Hoffenberg, Michael D. Kappelman & Richard B. Colletti. (2014) Implementable Strategies and Exploratory Considerations to Reduce Costs Associated with Anti-TNF Therapy in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:5, pages 946-951.
Crossref
Crossref
Fabiola Atzeni, Caterina Defendenti, Maria Chiara Ditto, Alberto Batticciotto, Donatella Ventura, Marco Antivalle, Sandro Ardizzone & Piercarlo Sarzi-Puttini. (2014) Rheumatic manifestations in inflammatory bowel disease. Autoimmunity Reviews 13:1, pages 20-23.
Crossref
Crossref
Jeannie K. Lee, Derek H. Tang, Lea Mollon & Edward P. Armstrong. (2013) Cost-effectiveness of biological agents used in ulcerative colitis. Best Practice & Research Clinical Gastroenterology 27:6, pages 949-960.
Crossref
Crossref
K. B. Lankarani. (2013) Letter: rapid infliximab infusion is not always safe. Alimentary Pharmacology & Therapeutics 38:7, pages 844-844.
Crossref
Crossref